Pascal Schmidt
Finanzdirektor/CFO bei MARINOMED BIOTECH AG
Ursprung des Netzwerks ersten Grades von Pascal Schmidt
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 12 | |
Aleph Zero Foundation
Aleph Zero Foundation Packaged SoftwareTechnology Services Aleph Zero Foundation is a Swiss company that provides an enterprise-ready, peer-reviewed blockchain solution. The company is based in Zug, Switzerland. The company's blockchain is scalable, fast, and developer-friendly. The company was founded by Michal Swietek, Adam Gagol, Antoni Zolciak, Matthew Niemerg.
4
| Holding Company | Packaged Software | 4 |
Mummert & Co. Corporate Finance GmbH
Mummert & Co. Corporate Finance GmbH Investment ManagersFinance Mummert & Co. Corporate Finance GmbH provides corporate finance advisory services. The company is based in Munich, Germany. Mummert & Co. Corporate Finance was acquired by Raymond James Financial, Inc. on June 01, 2016.
2
| Extinct | Investment Managers | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Pascal Schmidt
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
University of Vienna | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree Doctorate Degree Undergraduate Degree | |
Aravis AG
Aravis AG Investment ManagersFinance Aravis AG (Aravis) is an independent venture capital firm, founded in 2001 by Jean-Philippe Tripet and headquartered in Muttenz, Switzerland. | Investment Managers | Private Equity Investor | |
AUSTRIANOVA Biomanufacturing AG
AUSTRIANOVA Biomanufacturing AG BiotechnologyHealth Technology AUSTRIANOVA Biomanufacturing AG engages in the developmente of proprietary drug delivery technologies in orphan niche indications in oncology. It offers NovaCaps, which targets tumours in pancreatic cancer. The company was founded in 2001 and is headquartered in Vienna, Austria. | Biotechnology | Corporate Officer/Principal | |
Raymond James Corporate Finance GmbH
Raymond James Corporate Finance GmbH Miscellaneous Commercial ServicesCommercial Services Raymond James Corporate Finance GmbH provides consulting services in the areas of mergers and acquisitions, capital structures, acquisition financing, investments and divestments, as well as business strategies. The company is headquartered in Munich, Germany. | Miscellaneous Commercial Services | Chief Executive Officer | |
University of Graz | College/University | Doctorate Degree | |
Erdöl-Lagergesellschaft mbH
Erdöl-Lagergesellschaft mbH Other TransportationTransportation Erdöl-Lagergesellschaft mbH engages in the provision of crude oil storage services. It is responsible for maintaining energy supply security during emergencies. The firm also imports petroleum products to other European countries. The company was founded in 1976 and is headquartered in Lannach, Austria. | Other Transportation | Director/Board Member | |
University of Natural Resources & Life Sciences | College/University | Doctorate Degree | |
Onepharma | Corporate Officer/Principal | ||
Wyeth Pharmaceuticals BV | Corporate Officer/Principal | ||
Novartis Austria GmbH
Novartis Austria GmbH Pharmaceuticals: MajorHealth Technology Novartis Austria GmbH operates as a holding company, which engages in the development and production of pharmaceutical products. The company was founded on January 30, 2006 and is headquartered in Vienna, Austria. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Friedrich-Alexander University of Erlangen-Nuremberg | College/University | Masters Business Admin | |
TTTech Computertechnik AG
TTTech Computertechnik AG Computer Processing HardwareElectronic Technology TTTech Computertechnik AG engages in the provision of aerospace, space, manufacturing and energy market solutions. The company was founded by Stefan Poledna and Gerog Kopetz in 1998 and is headquartered in Vienna, Austria. | Computer Processing Hardware | Director/Board Member | |
WEB Windenergie AG
WEB Windenergie AG Electrical ProductsProducer Manufacturing WEB Windenergie AG provides renewable energy power. It offers wind energy, photovoltaic and hydroelectric power plants. The Company was founded by Erna Dangl, Frnaz Dangl and Andreas Dangl in 1994 and is headquartered in Pfaffenschlag, Austria. | Electrical Products | Director/Board Member | |
AMS-OSRAM AG | Semiconductors | Director/Board Member | |
Österreichische Bundesbahnen-Holding AG
Österreichische Bundesbahnen-Holding AG Air Freight/CouriersTransportation Österreichische Bundesbahnen-Holding AG engages in the holding and management of participations in companies of the ÖBB Group with focus on strategic orientation. It also provides infrastructure, transportation, and logistics services. The company was founded on April 20, 2004 and is headquartered in Vienna, Austria. | Air Freight/Couriers | Director/Board Member | |
Rail Cargo Austria AG
Rail Cargo Austria AG RailroadsTransportation Rail Cargo Austria AG engages in freight transport and logistics services. It specializes in wagonload and logistics, intermodal logistics, rolling road, railway undertaking, wagon rental and sales, as well as technical services and maintenance. The company was founded in 1992 and is headquartered in Vienna, Austria. | Railroads | Director/Board Member | |
ÖBB-Personenverkehr AG
ÖBB-Personenverkehr AG Other TransportationTransportation ÖBB-Personenverkehr AG provides passenger rail transportation. It operates suburban trains, long-distance trains, passenger wagons, railcars, and buses. The company was founded in 2004 and is headquartered in Vienna, Austria. | Other Transportation | Director/Board Member | |
Infineon Technologies Austria AG
Infineon Technologies Austria AG SemiconductorsElectronic Technology Infineon Technologies Austria AG engages in the development, production and sales of switching elements in microelectronics. The company was founded on March 24, 1999 and is headquartered in Villach, Austria. | Semiconductors | Director/Board Member | |
GREIFFENBERGER AG | Tools & Hardware | Director/Board Member | |
Lead Corporate Finance & Consulting GmbH | Chief Executive Officer | ||
SCHOELLER-BLECKMANN OILFIELD EQUIPMENT AG | Oilfield Services/Equipment | Director/Board Member | |
Laureo Corporate Finance GmbH | Chief Executive Officer | ||
AFFiRiS AG
AFFiRiS AG Medical/Nursing ServicesHealth Services AFFiRiS AG develops and produces vaccines for therapeutic treatment of chronic diseases. It provides research services and develops vaccines based on peptide antigens applied in the fields of biochemistry, molecular and cell biology, immunology and veterinary medicine. AFFiRiS was founded by Walter Schmidt and Frank Mattner in November 2003 and is headquartered in Vienna, Austria. | Medical/Nursing Services | Corporate Officer/Principal | |
Technische Universität München | College/University | Masters Business Admin | |
IMADEC University | College/University | Masters Business Admin | |
Vienna University of Economics & Business | College/University | Graduate Degree | |
Novartis Institutes for BioMedical Research GmbH & Co. KG | Director of Finance/CFO | ||
University of Zurich | College/University | Graduate Degree | |
UniCredit Bank GmbH
UniCredit Bank GmbH Regional BanksFinance UniCredit Bank AG provides banking services. It offers banking and financial products to corporate as well as public and private sector clients. The company operates through three segments: Commercial Banking, Corporate & Investment Banking and Other/Consolidation. The Commercial Banking segment offers consumer loans, mortgage loans, savings-and-loan and insurance products and banking services for retail customers. The corporate & Investment Banking segment operates through three divisions HVB, UniCredit Bank Austria AG and UniCredit spa. The other/consolidation segment encompasses the chief operating office business unit, activities of the group corporate center business unit and consolidation effects. The company was founded on July 1, 1869 and is headquartered in Munich, Germany. | Regional Banks | Corporate Officer/Principal | |
Ludwig-Maximilians-Universität München | College/University | Undergraduate Degree | |
Goetzpartners Securities Ltd.
Goetzpartners Securities Ltd. Investment Banks/BrokersFinance Goetzpartners Securities Ltd. is the Great Britain-based brokerage subsidiary of goetzpartners Corporate Finance GmbH, which is owned by goetzpartners Holding GmbH & Co. KG in Germany. Headquartered in London, the firm was founded in 2003 to serve as a corporate broker for European healthcare companies. Goetzpartners Securities offers their corporate clients direct and well-established institutional buy-side access. They also provide access to high-net-worth individuals who are investing in healthcare sectors. Their equity sales team has broad geographic coverage, and offers specialist insight into healthcare capital markets. | Investment Banks/Brokers | Chief Executive Officer | |
CRS Clinical Research Services Andernach GmbH
CRS Clinical Research Services Andernach GmbH Miscellaneous Commercial ServicesCommercial Services Part of LTS LOHMANN Therapie-Systeme AG, CRS Clinical Research Services Andernach GmbH engages in research and development in natural sciences, engineering, agricultural sciences and medicine. The company is based in Andernach, Germany. The CEO of the German company is Torben Thomsen. | Miscellaneous Commercial Services | Chief Executive Officer | |
GBA Gesellschaft für Bioanalytik mbH
GBA Gesellschaft für Bioanalytik mbH Miscellaneous Commercial ServicesCommercial Services GBA Gesellschaft für Bioanalytik mbH engages in provision of analytical laboratory and consulting services. The firm’s services include environmental analysis, food analysis, GBA pharma and commodities analysis. The company was founded by Erich Döllefeld on June 27, 1989 and is headquartered in Hamburg, Germany. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
ABF Pharmaceutical Services GmbH
ABF Pharmaceutical Services GmbH Pharmaceuticals: MajorHealth Technology ABF Pharmaceutical Services GmbH provides pharmaceutical services. The firm’s services include Clinical Trial Supply Services, Labeling and packaging, Storage, Import and Export, QP release, quality management, central lab supply services, PBMC and sourcing. The company was founded in 2004 and is headquartered in Vienna, Austria. | Pharmaceuticals: Major | Chief Executive Officer | |
Boehringer Ingelheim RCV GmbH & Co. KG
Boehringer Ingelheim RCV GmbH & Co. KG BiotechnologyHealth Technology Boehringer Ingelheim RCV GmbH & Co. KG develops and supplies biotherapeutic proteins, plasmid DNA and antibody fragments. The company was founded in 1885 by Albert Boehringer and is headquartered in Vienna, Austria. | Biotechnology | Director/Board Member | |
Siemens Holding SpA | Chairman | ||
JENOPTIK AG | Electronic Components | Director/Board Member | |
Digital Dr. House AG | Director/Board Member | ||
Quadia SA
Quadia SA Investment ManagersFinance Quadia SA (Quadia) is an independent investment firm founded in 2010. The firm is headquartered in Switzerland. | Investment Managers | Director/Board Member | |
Aravis Venture II LP
Aravis Venture II LP Investment ManagersFinance Aravis Venture II LP invests in biotechnological start-ups with growth potential. | Investment Managers | Director/Board Member | |
S*BIO Pte Ltd.
S*BIO Pte Ltd. Pharmaceuticals: MajorHealth Technology S*BIO is a privately-held biotech company focused on the research and clinical development of novel targeted small molecule drugs for the treatment of cancer with leading programs around histone deacetylases (HDAC) and kinases. S*BIO's lead candidate, SB939, entered the clinic in 2007. SB1518, S*BIO's potent and orally-active JAK2 inhibitor, entered the clinic in 2008 and has received orphan drug designation from the U.S. FDA. S*BIO has entered into a development collaboration, and option & license agreement with Onyx Pharmaceuticals, Inc. to develop and commercialize SB1518 and its other novel JAK2 inhibitor, SB1578. S*BIO's SB1317, a novel multikinase inhibitor, is in pre-clinical development and under a worldwide exclusive license with Tragara Pharmaceuticals, Inc. for its development and commercialization. In line with its vision to be a leading fully-integrated oncology-focused biotech company in Asia Pacific, S*BIO has established a state-of-the-art R&D infrastructure, complemented by a strong clinical development team. S*BIO has strong links with a network of medical oncologists in Asia Pacific and its investors include EDB Investments' biomedical sciences subsidiary Bio*One Capital, Aravis Ventures, Novartis Bioventures and other international funds. In 2009, S*BIO received the BioSpectrum Editor's Choice, Emerging BioScience Company of Singapore Award. | Pharmaceuticals: Major | Director/Board Member | |
DyCare
DyCare Medical SpecialtiesHealth Technology DyCare is a Spanish company that specializes in digital rehabilitation. The company is based in Barcelona, Spain. The company creates ultra-personalized exercises and monitor patients in a simple and effective way. The company's technology allows patients to perform therapeutic exercises using only their mobile phone or tablet camera, assisted by artificial intelligence. The company was founded by Silvia Raga and Ricardo Jauregui, who have been the CEOs since incorporation. | Medical Specialties | Director/Board Member | |
Evolva SA
Evolva SA Miscellaneous Commercial ServicesCommercial Services Evolva SA is a Swiss-headquartered, international pharmaceutical biotech company focused on the discovery and development of drugs based on its distinctive and proprietary genetic chemistry platform. The company was founded in Switzerland in 2004 based on US/Danish technology. Evolva is headquartered in Allschwil/Basel with operations in Denmark, India and the USA. The Company has raised CHF 38.2 million of equity to date and employs 75 persons of whom 30 are based in Allschwil. The firm's strategy and business approach is based on five pillars that offer a sustainable development path for creating a successful company, which include Building a balanced portfolio. Evolva focuses on orally available small molecules in the belief that they are more convenient for patients and more cost-effective both from manufacture and administration points of view for the society, focus on differentiated pharmaceutical products with major benefits. Focusing on cardiovascular/renal and infectious diseases. Together they cause more than 50% of all deaths worldwide. Most of the top 20 pharmaceutical companies are active in both sectors, and all are active in one of the two sectors - hence widening Evolva's opportunities to partner. Building technology platform as the source of this differentiation. Evolva finds different structures with different properties from those found by the 99% of the industry that focuses on synthetic chemistry or proteins. Openness to unusual markets. The biotech business model has changed. As well as the established markets new opportunities arise in emerging countries such as India and China, and in adjacent sectors such as treatments against potential bio-terrorist and bio-warfare agents and the production of pharmaceutical and industrial chemical intermediates. Cost-effective implementation. Evolva places different functions around the globe according to where local conditions best suit. This approach both reduces Evolva's cost base and increases access to revenues, partners and talent. Evolva sees revenues and partners as important because they provide additional flexibility, resources and talent. Also, they provide important opportunities to better understand, and better meet, the needs of current and future customers. | Miscellaneous Commercial Services | Corporate Secretary |
Statistik
International
Österreich | 24 |
Deutschland | 11 |
Schweiz | 9 |
Vereinigtes Königreich | 3 |
Italien | 2 |
Sektoral
Consumer Services | 10 |
Finance | 9 |
Health Technology | 7 |
Commercial Services | 5 |
Transportation | 5 |
Operativ
Director/Board Member | 44 |
Corporate Officer/Principal | 20 |
Founder | 9 |
Chief Executive Officer | 8 |
Chairman | 8 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Pascal Schmidt
- Unternehmensverbindungen